Terms: = Lung cancer AND CEACAM5, CEA AND Treatment
702 results:
1. Clinical effect of anlotinib in combination with docetaxel in treating advanced non-small cell lung cancer.
Weng G; Fang W; Lin Y; Chen L; Su W
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):212-216. PubMed ID: 38678603
[TBL] [Abstract] [Full Text] [Related]
2. Application Value of CYFRA21-1 Combined with NSE, cea, and SCC-Ag in lung cancer.
Fu Y; Li D; Zhu Y; Yan S; Wang X; Lian Z; Xie Q; He Z
Clin Lab; 2024 Apr; 70(4):. PubMed ID: 38623667
[TBL] [Abstract] [Full Text] [Related]
3. [Clinical characteristics and prognosis analysis of 17 cases of SMARCA4-deficient chest tumors].
Cao XN; Li Z; Wang QY
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Apr; 47(4):325-331. PubMed ID: 38599807
[No Abstract] [Full Text] [Related]
4. Determination of Tumor Marker Screening for lung cancer Using ROC Curves.
Dou X; Lu J; Yu Y; Yi Y; Zhou L
Dis Markers; 2024; 2024():4782618. PubMed ID: 38549716
[TBL] [Abstract] [Full Text] [Related]
5. Development and validation of comprehensive nomograms from the SEER database for predicting early mortality in metastatic rectal cancer patients.
Li Y; Tao T; Liu Y
BMC Gastroenterol; 2024 Feb; 24(1):89. PubMed ID: 38408896
[TBL] [Abstract] [Full Text] [Related]
6. Distinction of ALK fusion gene- and EGFR mutation-positive lung cancer with tumor markers.
Akita T; Ariyasu R; Kakuto S; Miyadera K; Kiritani A; Tsugitomi R; Amino Y; Uchibori K; Kitazono S; Yanagitani N; Tasaka S; Nishio M
Thorac Cancer; 2024 Apr; 15(10):788-796. PubMed ID: 38400801
[TBL] [Abstract] [Full Text] [Related]
7. Relevance of tumor markers for prognosis and predicting therapy response in non-small cell lung cancer patients: A CEPAC-TDM biomarker substudy.
Geiger K; Joerger M; Roessler M; Hettwer K; Ritter C; Simon K; Uhlig S; Holdenrieder S
Tumour Biol; 2024; 46(s1):S191-S206. PubMed ID: 38363625
[TBL] [Abstract] [Full Text] [Related]
8. Clinical impact of pleural fluid carcinoembryonic antigen on therapeutic strategy and efficacy in lung adenocarcinoma patients with malignant pleural effusion.
Lee J; Lee DH; Park JE; Lee YH; Choi SH; Seo H; Yoo SS; Lee SY; Cha SI; Park JY; Kim CH
Korean J Intern Med; 2024 Mar; 39(2):318-326. PubMed ID: 38351680
[TBL] [Abstract] [Full Text] [Related]
9. Molecular alterations and clinical prognostic factors in resectable non-small cell lung cancer.
Thamrongjirapat T; Muntham D; Incharoen P; Trachu N; Sae-Lim P; Sarachai N; Khiewngam K; Monnamo N; Kantathut N; Ngodngamthaweesuk M; Ativitavas T; Chansriwong P; Nitiwarangkul C; Ruangkanchanasetr R; Kositwattanarerk A; Sirachainan E; Dejthevaporn T; Reungwetwattana T
BMC Cancer; 2024 Feb; 24(1):200. PubMed ID: 38347487
[TBL] [Abstract] [Full Text] [Related]
10. cea Negative Initial Diagnosis of HP Infection Finally Confirmed by Bronchoscopic Biopsy as lung Adenocarcinoma.
Zhao Q; Ren HQ; Jiang J; Yang W; Yao XX; Zhang L; Sun SY; Ge YL
Clin Lab; 2024 Feb; 70(2):. PubMed ID: 38345979
[TBL] [Abstract] [Full Text] [Related]
11. [A Case of Long-Term Survival with Metachronous Hepatic and Pulmonary Metastases from Transverse Colon cancer by Multidisciplinary treatment].
Hara T; Okano M; Hata T; Takayama O; Kim Y; Imamoto H; Hasegawa J
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1857-1859. PubMed ID: 38303231
[TBL] [Abstract] [Full Text] [Related]
12. Improvement of differential diagnosis of lung cancer by use of multiple protein tumor marker combinations.
Trulson I; Klawonn F; von Pawel J; Holdenrieder S
Tumour Biol; 2024; 46(s1):S81-S98. PubMed ID: 38277317
[TBL] [Abstract] [Full Text] [Related]
13. [A Case of Gastric cancer with Pulmonary Carcinomatous Lymphangitis and Disseminated Carcinomatosis of the Bone Marrow Responding to S-1 plus Cisplatin Chemotherapy].
Otsuka N; Shirayama K
Gan To Kagaku Ryoho; 2023 Dec; 50(12):1319-1321. PubMed ID: 38247072
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic and predictive biomarkers in non-small cell lung carcinoma.
Odintsov I; Sholl LM
Pathology; 2024 Mar; 56(2):192-204. PubMed ID: 38199926
[TBL] [Abstract] [Full Text] [Related]
15. Immunotherapy in mismatch repair-deficient metastatic colorectal cancer - Outcome and novel predictive markers.
Stemmer A; Margalit O; Serpas V; Strauss G; Thomas J; Shah P; Tau N; Levanon K; Shacham-Shmueli E; Kopetz S; Overman M; Boursi B
Eur J Cancer; 2024 Feb; 198():113495. PubMed ID: 38157568
[TBL] [Abstract] [Full Text] [Related]
16. Selection of potential targets for stratifying congenital pulmonary airway malformation patients with molecular imaging: is MUC1 the one?
van Horik C; Zuidweg MJP; Boerema-de Munck A; Buscop-van Kempen M; Brosens E; Vahrmeijer AL; von der Thüsen JH; Wijnen RMH; Rottier RJ; Tummers WSFJ; Schnater JM
Eur Respir Rev; 2023 Dec; 32(170):. PubMed ID: 38123235
[TBL] [Abstract] [Full Text] [Related]
17. Inhibitory effects of the nanoscale lysate derived from xenogenic dental pulp stem cells in lung cancer models.
He Y; Li R; She W; Ai Y; Li K; Kumeria T; Jiang Z; Shao Q; Zou C; Albashari AA; Duan X; Ye Q
J Nanobiotechnology; 2023 Dec; 21(1):488. PubMed ID: 38105218
[TBL] [Abstract] [Full Text] [Related]
18. Correlation between carcinoembryonic antigen (cea) expression and EGFR mutations in non-small-cell lung cancer: a meta-analysis.
Gan T; An W; Long Y; Wang J; Zhang H; Liao M
Clin Transl Oncol; 2024 Apr; 26(4):991-1000. PubMed ID: 38030870
[TBL] [Abstract] [Full Text] [Related]
19. Predictive value of
Zhang Q; Tao X; Yuan P; Zhang Z; Ying J; Guo L; Li N; Wang S; Li J; Liu Y; Guo W; Zhao S; Wu N
Cancer Med; 2023 Nov; 12(22):20864-20877. PubMed ID: 37965789
[TBL] [Abstract] [Full Text] [Related]
20. Cost-effectiveness of first-line immunotherapy for advanced non-small cell lung cancer with different PD-L1 expression levels: A comprehensive overview.
Wu C; Li W; Tao H; Zhang X; Xin Y; Song R; Wang K; Zuo L; Cai Y; Wu H; Hui W
Crit Rev Oncol Hematol; 2024 Jan; 193():104195. PubMed ID: 37931769
[TBL] [Abstract] [Full Text] [Related]
[Next]
